This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
|Articles|November 13, 2015
Print and Apply Labeler Has High-Resolution Coding
Domino’s new M230i print-and-apply labeler is designed for secondary and tertiary packaging applications.
Advertisement
Domino’s new M230i is designed for secondary and tertiary packaging applications. The unit incorporates Domino’s intelligent Technology (i-Tech) and QuickStep user interface. The M-Series range of print and apply units offer a modular solution to meet the various case and pallet labeling needs of manufacturers.
It features high-resolution online coding, that allows for the application of barcodes, text, and graphics on packaging labels, ensuring full GS1 supply-chain compliance.
The inclusion of tool-free, magnetic print-head mounting allows for minimum downtime, as well as a wide range of standard applicators such as tamp, blow, wipe, and corner wrap. Additionally, a higher print speed allows reduced cycle times, which makes the unit suitable for faster production lines. The M230i includes left and right hand versions, as well as a robust design to guarantee longevity and support all printer orientations.
Advertisement
Related to this article
Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.
PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Advertisement
Advertisement